Presentation on theme: "IS OCCASIONAL CONSULTATION AT A SPECIALIZED HYPERTENSION CLINIC BENEFICIAL FOR CARDIOVASCULAR RISK PROFILE IN HYPERTENSIVES DURING 5-YEAR FOLLOW-UP? M."— Presentation transcript:
IS OCCASIONAL CONSULTATION AT A SPECIALIZED HYPERTENSION CLINIC BENEFICIAL FOR CARDIOVASCULAR RISK PROFILE IN HYPERTENSIVES DURING 5-YEAR FOLLOW-UP? M. Marciniak, K. Słupek, J. Kolbusz, Scientific supervisors: P. Jędrusik, B. Symonides, Z. Gaciong Students' Research Group at the Department of Internal Medicine, Hypertension and Angiology Medical University of Warsaw
OBJECTIVE To assess cardiovascular (CV) risk profile during 5- year follow-up of patients with hypertension (HTN) remaining in the care of family physicians (GPs) and additionally only occasionally attending a specialized HTN day-clinic in our tertiary referral center.
DESIGN & METHODS Studied population n=200 114 women 86 men Mean age: 51,8 ± 14,1 yrs Median HTN duration: 5 yrs Preexisting CV disease - 33% Diabetes mellitus - 13% Proteinuria and/or renal dysfunction- 9%
DESIGN & METHODS Recrutation Patients attending specialized HTN day-clinic in 2000 Single consultation ≤1/year at the request of a GP Follow-up : invitation in 2005 Invitation by mail Phone questionnaire Statistical analysis t-Student test, Chi² – test p<0,05
THE DAY-CLINIC Indications for referral: - Newly diagnosed HTN - Suspicion of secondary HTN - HTN resistant to treatment Frequency of consultations : 1/year / patient
THE DAY-CLINIC Routine evaluation/intervention during visit: –Ambulatory blood pressure monitoring (ABPM) –ECG, routine clinical biochemistry, search for secondary causes of HTN when clinically indicated –Modification of pharmacotherapy –Advice on lifestyle modification
AVERAGE NUMBER OF DRUGS TAKEN 2000 2,0±1,3/ patient 2005
CONCLUSIONS Even infrequent consultations at a specialized HTN clinic result in improved BP control, lipid levels and lower global CV risk in hypertensives at 5-year follow-up despite advancement in age. No increase in the average number of drugs taken may result from better choice of therapy applied. Such a “backup” for primary care physicians might represent a feasible, possibly relatively low-cost strategy to reduce CV disease burden in general population.